Vaccination en périnatalité : parents, enfants, professionnels

Pinquier, Didier; Gagneur, Arnaud; Guen, C. Gras-Le; Blandin, S.; Regnier, F.; Picherot, G.; Brissaud, O.; Marpeau, L.; Marret, Stéphane; Reinert, Philippe

doi:10.1016/j.gyobfe.2008.02.015

Cited by 6 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…En ce qui concerne le risque viral et en admettant que la couverture vaccinale de la mère soit à jour, le nouveau-né est protégé pendant quelques mois par les anticorps maternels vis-à-vis de certaines maladies à prévention vaccinale [1]. Le cas particulier de la prévention antituberculeuse relève désormais de la réali-sation du BCG intradermique chez le nouveau-né, dans certaines populations à risque (migrants par exemple), non immunodéprimées (VIH) [2]. Plus tard, selon leur couverture vaccinale ou leur immunité, les enfants peuvent encore être sensibles à des maladies hautement contagieuses, telles que la rougeole, les oreillons, la rubéole (vaccins ou rappels non faits).…”

Section: Particularités Du Patient Pédiatriqueunclassified

Infections nosocomiales en réanimation pédiatrique

Boyer¹,

Guyard²,

Caseris³

et al. 2013

Réanimation Pédiatrique

Self Cite

View full text Add to dashboard Cite

PréambuleNous ne traiterons dans ce chapitre que le cas des nourrissons et enfants admis en réanimation médico-chirurgicale, en excluant notamment les nouveau-nés prématurés. Les mesures applicables à tout malade hospitalisé indé-pendamment de son âge (par exemple, usage des solutions hydro-alcooliques, isolement par confi nement des germes à potentiel épidémique) ne seront pas abordées dans leurs aspects, hors spécifi cités pédiatriques.V. Laudenbach ( ), Unité fonctionnelle de réanimation pédiatrique, service de pédiatrie néonatale et réanimation,

show abstract

Section: Particularités Du Patient Pédiatriqueunclassified

Infections nosocomiales en réanimation pédiatrique

Boyer¹,

Guyard²,

Caseris³

et al. 2013

Réanimation Pédiatrique

Self Cite

View full text Add to dashboard Cite

show abstract

“…Clinicians and HCWs can play a critical role in educating the public. Healthcare providers are cited as the most frequent source of immunization information by parents, including parents of unvaccinated children (Pinquier et al 2008;Dubé et al 2010). It is not clear to what extent non-compliance among HCWs does influence the general public attitudes toward seasonal influenza immunizations.…”

Section: Usmentioning

confidence: 99%

Influenza Immunization: Synthesizing and Communicating the Evidence

Nicogossian

Ebadirad

Zimmerman

et al. 2010

World Med & Health Policy

View full text Add to dashboard Cite

Objective: To synthesize the evidence underpinning the benefits and risks of influenza vaccination for inclusion in communication and outreach campaigns. Background: Influenza A virus is a seasonal contributor to worldwide morbidity and mortality. Children, the immunocompromised, and the elderly are at higher risk of influenza complications. Compliance with vaccination remains below the optimum effectiveness level despite an estimated annual global mortality of 300,000 to 500,000. Methods: Publications describing concerns and objections to the influenza vaccination were reviewed. Based on these reviews, Medical Subject Heading (MeSH) terms were selected to query major databases for relevant information on effectiveness, risks, compliance, and acceptance of seasonal and 2009 pandemic influenza vaccines. A standardized approach to the rating of the evidence was developed. The synthesized evidence on vaccine effectiveness, enacted medical and public health policies, and communication practices was discussed with a group of experts and subjected to an external peer review. Results: Prior surveys identified poor understanding of influenza health risks and lack of access to the vaccine as major objections to immunization. There is good evidence that the seasonal vaccine provides protection against influenza, and vaccine complications are rare. Influenza vaccination rates remain low suggesting that the potential economic and health benefits of the vaccine have not yet been realized. Epidemiological studies quantifying the success of the general public's use of precautionary practices are lacking. Prospective studies on vaccine efficacy were not found in the published literature. Few cross‐sectional studies on immunization compliance among healthcare workers (HCWs) and different population groups were found in our literature searches. Well‐designed epidemiological studies on the benefits and risks of influenza vaccination programs are available for a limited number of countries and select population groups. Discussion: It is postulated that the success of an immunization program depends on advanced planning and sustained communication campaigns. Evidence‐based education on the benefits of vaccination can help improve compliance among HCWs and the public. Interpreting and explaining scientific data end knowledge is complex, and conveying this information to the public should target primarily the benefits and risks of vaccination. Educational campaigns should include well‐defined strategies compatible with cultural, behavioral, and social constructs of each community. Conclusions: There is good evidence that seasonal influenza vaccination is a reliable and effective public health tool for reducing the adverse health and economic consequences of this disease. This evidence should be clearly articulated in all influenza educational and outreach campaigns. Evidence supporting the added efficacy of influenza vaccines, together with physical and sanitary measures to interrupt transmission, should be the subject of addi...

show abstract